Breakthroughs
FDA Approves Daraxonrasib (Rasonque): A Breakthrough Treatment for Pancreatic Cancer
A New Era for One of the Deadliest Cancers The U.S. Food and Drug Administration (FDA) has approved daraxonrasib (brand name Rasonque) — a first-in-class...